Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. (May 2015)
- Record Type:
- Journal Article
- Title:
- Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease. (May 2015)
- Main Title:
- Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease
- Authors:
- Gupta, Vandana
Banyard, Antonia
Mullan, Aoibheann
Sriskantharajah, Srividya
Southworth, Thomas
Singh, Dave - Abstract:
- Abstract : Aims: Lipopolysaccharide (LPS) inhalation causes increased airway and systemic inflammation. We investigated LPS inhalation in patients with chronic obstructive pulmonary disease (COPD) as a model of bacterial exacerbations. We studied safety, changes in sputum and systemic biomarkers. We have also investigated interleukin (IL)‐17 concentrations in this model. Methods: Twelve COPD patients inhaled 5 μg LPS. Safety was monitored over 24 h. Sputum was induced at baseline, 6 and 24 h for cells and IL‐8, IL‐17, neutrophil elastase, monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1β (MIP‐1β) in supernatants. Serum was collected at baseline, 4, 8 and 24 h for IL‐6, C‐reactive protein (CRP) and Clara cell protein (CC‐16) concentrations. Peripheral blood mononuclear cells (PBMCs) were isolated at baseline and 4 h for systemic IL‐17 analysis. Results: LPS 5 μg was well tolerated. The greatest FEV1 change was 11.7% (mean) at 1 h (95% CI 5.1–18.2%). There was a large range in maximal fall (2.5–37.7%). Total sputum cell count and neutrophil count significantly increased 6 and 24 h post‐LPS. There was no change in sputum supernatant mediators. IL‐6, CRP and CC‐16 increased post‐inhalation, with different temporal patterns. CD4+ and CD8+ cell associated IL‐17 significantly increased at 4 h. Conclusions: Inhaled LPS in COPD patients safely causes increased airway and systemic inflammation. This may be a model for studying COPD exacerbations.
- Is Part Of:
- British journal of clinical pharmacology. Volume 79:Number 5(2015:May)
- Journal:
- British journal of clinical pharmacology
- Issue:
- Volume 79:Number 5(2015:May)
- Issue Display:
- Volume 79, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 79
- Issue:
- 5
- Issue Sort Value:
- 2015-0079-0005-0000
- Page Start:
- 767
- Page End:
- 776
- Publication Date:
- 2015-05
- Subjects:
- COPD -- COPD exacerbations -- IL‐17 -- lipopolysaccharide -- sputum neutrophils
Pharmacology -- Periodicals
Drugs -- Periodicals
615.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2125 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcp.12546 ↗
- Languages:
- English
- ISSNs:
- 0306-5251
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2307.180000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4773.xml